1.Dean, DJ, Orr, JM, Bernard, JA, et al. Hippocampal shape abnormalities predict symptom progression in neuroleptic-free youth at ultrahigh risk for psychosis. Schizophr Bull. 2016; 42(1): 161–169.
2.Buehlmann, E, Berger, GE, Aston, J, et al. Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study. J Psychiatr Res. 2010; 44(7): 447–453.
3.Anvari, AA, Friedman, LA, Greenstein, D, Gochman, P, Gogtay, N, Rapoport, JL. Hippocampal volume change relates to clinical outcome in childhood-onset schizophrenia. Psychol Med. 2015; 45(12): 2667–2674.
4.Csernansky, JG, Joshi, S, Wang, L, et al. Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci U S A. 1998; 95(19): 11406–11411.
5.Walter, A, Studerus, E, Smieskova, R, et al. Hippocampal volume in subjects at high risk of psychosis: a longitudinal MRI study. Schizophr Res. 2012; 142(1–3): 217–222.
6.Bois, C, Levita, L, Ripp, I, et al. Hippocampal, amygdala and nucleus accumbens volume in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison. Schizophr Res. 2015; 165(1): 45–51.
7.Vargas, T, Dean, DJ, Osborne, KJ, et al. Hippocampal Subregions Across the Psychosis Spectrum. Schizophr Bull. 2018; 44(5): 1091–1099.
8.Baglivo, V, Cao, B, Mwangi, B, et al. Hippocampal subfield volumes in patients with first-episode psychosis. Schizophr Bull. 2018; 44(3): 552–559.
9.Ho, NF, Holt, DJ, Cheung, M, et al. Progressive decline in hippocampal CA1 volume in individuals at ultra-high-risk for psychosis who do not remit: findings from the Longitudinal Youth at Risk Study. Neuropsychopharmacology. 2017; 42(6): 1361–1370.
10.Addington, J, Brooks, BL, Addington, D. Cognitive functioning in first episode psychosis: initial presentation. Schizophr Res. 2003; 62(1–2): 59–64.
11.Wood, SJ, Brewer, WJ, Koutsouradis, P, et al. Cognitive decline following psychosis onset: data from the PACE clinic. Br J Psychiatry Suppl. 2007; 51: S52–57.
12.Bilder, RM, Goldman, RS, Robinson, D, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am J Psychiatry. 2000; 157(4): 549–559.
13.Watson, DR, Bai, F, Barrett, SL, et al. Structural changes in the hippocampus and amygdala at first episode of psychosis. Brain Imaging Behav. 2012; 6(1): 49–60.
14.Ellison-Wright, I, Glahn, DC, Laird, AR, Thelen, SM, Bullmore, E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008; 165(8): 1015–1023.
15.Gur, RE, Keshavan, MS, Lawrie, SM. Deconstructing psychosis with human brain imaging. Schizophr Bull. 2007; 33(4): 921–931.
16.Ota, M, Obu, S, Sato, N, Asada, T. Neuroimaging study in subjects at high risk of psychosis revealed by the Rorschach test and first-episode schizophrenia. Acta Neuropsychiatr. 2011; 23(3): 125–131.
17.Brewer, WJ, Wood, SJ, Phillips, LJ, et al. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull. 2006; 32(3): 538–555.
18.Bora, E, Lin, A, Wood, SJ, Yung, AR, McGorry, PD, Pantelis, C. Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. Acta Psychiatr Scand. 2014; 130(1): 1–15.
19.Lencz, T, Smith, CW, McLaughlin, D, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2006; 59(9): 863–871.
20.Mathew, I, Gardin, TM, Tandon, N, et al. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. JAMA Psychiatry. 2014; 71(7): 769–777.
21.Harrisberger, F, Smieskova, R, Vogler, C, et al. Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis. Transl Psychiatry. 2016; 6(8): e868.
22.Vassos, E, Di Forti, M, Coleman, J, et al. An examination of polygenic score risk prediction in individuals with first-episode psychosis. Biol Psychiatry. 2017; 81(6): 470–477.
23.Kebir, O, Chaumette, B, Krebs, MO. Epigenetic variability in conversion to psychosis: novel findings from an innovative longitudinal methylomic analysis. Transl Psychiatry. 2018; 8(1): 93.
24.Kebir, O, Chaumette, B, Rivollier, F, et al. Methylomic changes during conversion to psychosis. Mol Psychiatry. 2017; 22(4): 512–518.
25.First, MB, Spitzer, RL, Gibbon, M, Williams, JB. Structured Clinical Interview for DSM-IV TR Axis I Disorders, Research Version, Patient Edition. New York State Psychiatric Institute, Biometrics Research; New York: 2001.
26.Wechsler, DS, Engstrom, LD, Alexander, BM, Motto, DG, Roulston, D. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein. Genes Chromosomes Cancer. 2003; 36(1): 26–36.
27.Wechsler, D, Kaplan, E, Fein, D, et al. Wechsler Intelligence Scale for Children Fourth Edition–Integrated: Technical and Interpretative Manual. San Antonio, TX: The Psychological Corporation; 2004.
28.Wechsler, D, Coalson, DL, Raiford, SE. WAIS-IV: Wechsler Adult Intelligence Scale. San Antonio, TX: Pearson; 2008.
29.Randolph, C, Tierney, MC, Mohr, E, Chase, TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol. 1998; 20(3): 310–319.
30.Beatty, WW, Mold, JW, Gontkovsky, ST. RBANS performance: influences of sex and education. J Clin Exp Neuropsychol. 2003; 25(8): 1065–1069.
31.Reitan, RM, Wolfson, D. Category Test and Trail Making Test as measures of frontal lobe functions. The Clinical Neuropsychologist. 1995; 9(1): 50–56.
32.Morey, L. Personality Assessment Inventory professional manual 2nd ed. Lutz, FL: Psychological Assessment Resources; 2007.
33.Rorschach, H. Psychodiagnostics—A Diagnostic Test Based on Perception. Read Books Ltd; 2013. Germany.
34.Gur, RC, Calkins, ME, Satterthwaite, TD, et al. Neurocognitive growth charting in psychosis spectrum youths. JAMA Psychiatry. 2014; 71(4): 366–374.
35.Gur, RE, Keshavan, MS, Lawrie, SM. Deconstructing psychosis with human brain imaging. In: Tamminga CA, Sirovatka PJ, Regier DA, Os Jv, eds. Deconstructing psychosis: Refining the research agenda for DSM-V. Arlington, VA: American Psychiatric Association; 2010: 109–129.
36.Lappin, JM, Morgan, C, Chalavi, S, et al. Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes. Psychol Med. 2014; 44(6): 1279–1291.
37.Green, MF. Cognitive remediation in schizophrenia: is it time yet? Am J Psychiatry. 1993; 150(2): 178–187.
38.Morales-Muñoz, I, Jurado-Barba, R, Fernández-Guinea, S, et al. Cognitive impairments in patients with first episode psychosis: the relationship between neurophysiological and neuropsychological assessments. J Clin Neurosci. 2017; 36: 80–87.
39.Lecardeur, L, Meunier-Cussac, S, Dollfus, S. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment]. Encephale. 2013; 39(Suppl 1): S64–71.
40.Hyza, M, Huttlova, J, Kerkovsky, M, Kasparek, T. Psychosis effect on hippocampal reduction in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 48: 186–192.
41.Pantelis, C, Yucel, M, Wood, SJ, McGorry, PD, Velakoulis, D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry. 2003; 37(4): 399–406.
42.Velakoulis, D, Wood, SJ, McGorry, PD, Pantelis, C. Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Aust N Z J Psychiatry. 2000; 34(Suppl 2): S113–126.
43.Velakoulis, D, Wood, SJ, Wong, MTH, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry. 2006; 63(2): 139–149.
44.Nelson, MD, Saykin, AJ, Flashman, LA, Riordan, HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry. 1998; 55(5): 433–440.
45.Perkins, DO, Gu, H, Boteva, K, Lieberman, JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005; 162(10): 1785–1804.
46.Bradford, DW, Perkins, DO, Lieberman, JA. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses. Drugs. 2003; 63(21): 2265–2283.
47.Nenadic, I, Dietzek, M, Schönfeld, N, et al. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study. Schizophr Res. 2015; 161(2–3): 169–176.
48.Brent, BK, Thermenos, HW, Keshavan, MS, Seidman, LJ. Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings. Child Adolesc Psychiatr Clin N Am. 2013; 22(4): 689–714.
49.Stone, JM, Day, F, Tsagaraki, H, et al. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry. 2009; 66(6): 533–539.
50.Clancy, MJ, Clarke, MC, Connor, DJ, Cannon, M, Cotter, DR. The prevalence of psychosis in epilepsy: a systematic review and meta-analysis. BMC Psychiatry. 2014; 14: 75.